Cannabis interacts with CB1 and CB2 receptors throughout the gut and immune system to reduce inflammation, motility, and secretions, showing symptomatic benefits in small IBD studies, but large controlled trials are still lacking.
IBD patients exploring cannabis, gastroenterologists, and medical cannabis researchers.
Cannabinoids reduce gut motility, secretions, and inflammatory edema through CB1 and CB2 receptors
What the researchers found
Cannabinoids act on CB1 and CB2 receptors in the enteric nervous system, GI epithelial cells, and immune cells, reducing gut motility, secretions, and inflammatory edema. Small observational studies and placebo-controlled trials have shown symptomatic improvement, but sample sizes have been too small for firm efficacy and safety conclusions.
Why it matters
IBD affects millions of people globally, and current treatments often have significant side effects or lose effectiveness over time. Cannabis represents a potentially well-tolerated complementary approach, but the evidence gap is significant.
The numbers in context
CB1 and CB2 receptors expressed in brain, enteric nervous system, GI epithelial cells, and immune cells; effects: decreased gut motility, reduced secretions, reduced inflammatory edema
How the study worked
Narrative review of observational and placebo-controlled trials examining cannabis and cannabinoids in Crohn's disease and ulcerative colitis, alongside preclinical mechanism data.
What this study cannot tell us
Narrative review. Existing clinical trials have small sample sizes. No standardized cannabinoid compositions across studies. Long-term safety data lacking. Psychotropic side effects of THC limit some applications.
How to read the evidence
Narrative review of small clinical studies. Biological rationale is strong but clinical evidence remains limited.
When this study was published
Published in 2024.
The bigger picture
The endocannabinoid system's extensive presence in the gut provides a strong biological rationale for cannabinoid therapy in IBD. The challenge is moving from preclinical promise to clinical evidence through adequately powered trials.
Questions still open
- Would standardized cannabis preparations with specific cannabinoid ratios be more effective for IBD?
- Could cannabis derivatives without psychoactive effects provide the anti-inflammatory benefits needed?
Common questions
Can cannabis help with IBD?
How does cannabis work in the gut?
Read the original research
The Potential of Cannabis in Managing Inflammatory Bowel Disease and Its Future Perspective.
Cureus, 16(10), e71068
Citation
Rauf, Arsalan; Nisar, Mudassar; Shaeel, Muhammad; Athar, Ali; Rehman, Muhammad Mujtaba Ur; Faheem, Filzah. (2024). The Potential of Cannabis in Managing Inflammatory Bowel Disease and Its Future Perspective.. Cureus, 16(10), e71068. https://doi.org/10.7759/cureus.71068
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk